Vericel (VCEL) Current Leases (2019 - 2026)
Vericel's (VCEL) quarterly Current Leases came in at $14.1 million in Q1 2026, up 25.98% year-on-year from $11.2 million in Q1 2025, and up 0.67% quarter-over-quarter from $14.0 million in Q4 2025.
Vericel (VCEL) Current Leases (2019 - 2026) Analysis & Trends
Vericel has disclosed Current Leases across 8 years of filings, most recently posting $14.1 million for Q1 2026.
- Current Leases for Q1 2026 came in at $14.1 million, up 25.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.1 million (up 25.98% YoY), and the FY2025 annual result was $14.0 million, up 50.9% from the prior year.
- Current Leases came in at $14.1 million for Q1 2026 at Vericel, up from $14.0 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $14.1 million in Q1 2026 to a low of $3.2 million in Q2 2022.
- The 5-year median for Current Leases is $6.2 million (2023), against an average of $7.9 million.
- Across the five-year window, Current Leases tumbled 31.55% in 2022 and jumped 137.49% in 2025, its largest moves.
- Vericel's Current Leases stood at $4.3 million in 2022, then surged by 43.82% to $6.2 million in 2023, then surged by 49.62% to $9.3 million in 2024, then jumped by 50.9% to $14.0 million in 2025, then advanced by 0.67% to $14.1 million in 2026.
- The last three Current Leases figures came in at $14.1 million (Q1 2026), $14.0 million (Q4 2025), and $13.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | 14.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.06 Mn |
| Dec 31, 2025 | 13.97 Mn |
| Sep 30, 2025 | 13.85 Mn |
| Jun 30, 2025 | 13.75 Mn |
| Mar 31, 2025 | 11.16 Mn |
| Dec 31, 2024 | 9.26 Mn |
| Sep 30, 2024 | 6.12 Mn |
| Jun 30, 2024 | 5.79 Mn |
| Mar 31, 2024 | 6.01 Mn |
| Dec 31, 2023 | 6.19 Mn |
| Sep 30, 2023 | 7.27 Mn |
| Jun 30, 2023 | 7.22 Mn |
| Mar 31, 2023 | 4.50 Mn |
| Dec 31, 2022 | 4.30 Mn |
| Sep 30, 2022 | 4.90 Mn |
| Jun 30, 2022 | 3.16 Mn |
| Mar 31, 2022 | 3.19 Mn |
| Dec 31, 2021 | 2.95 Mn |
| Sep 30, 2021 | 2.28 Mn |
| Jun 30, 2021 | 4.61 Mn |